Ratings for Comerica CMA were provided by 16 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 5 | 7 | 4 | 0 |
| Last 30D | 0 | 0 | 0 | 1 | 0 |
| 1M Ago | 0 | 3 | 3 | 2 | 0 |
| 2M Ago | 0 | 1 | 3 | 1 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $60.81, a high estimate of $75.00, and a low estimate of $47.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 12.5%.
Investigating Analyst Ratings: An Elaborate Study
The analysis of recent analyst actions sheds light on the perception of Comerica by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Chiaverini | Jefferies | Announces | Underperform | $47.00 | - |
| Brandon King | Truist Securities | Lowers | Hold | $57.00 | $65.00 |
| Ryan Nash | Goldman Sachs | Lowers | Neutral | $57.00 | $66.00 |
| Karl Shepard | RBC Capital | Lowers | Outperform | $65.00 | $75.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Lowers | Outperform | $68.00 | $77.00 |
| John Pancari | Evercore ISI Group | Lowers | Underperform | $50.00 | $65.00 |
| Mike Mayo | Wells Fargo | Lowers | Equal-Weight | $55.00 | $67.00 |
| David George | Baird | Lowers | Outperform | $75.00 | $80.00 |
| Anthony Elian | JP Morgan | Lowers | Underweight | $52.00 | $64.00 |
| Nicholas Holowko | UBS | Announces | Neutral | $59.00 | - |
| Manan Gosalia | Morgan Stanley | Lowers | Underweight | $55.00 | $63.00 |
| Michael Rose | Raymond James | Lowers | Outperform | $67.00 | $72.00 |
| Terry McEvoy | Stephens & Co. | Lowers | Equal-Weight | $64.00 | $66.00 |
| Mike Mayo | Wells Fargo | Lowers | Equal-Weight | $67.00 | $70.00 |
| Manan Gosalia | Morgan Stanley | Lowers | Equal-Weight | $63.00 | $71.00 |
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $72.00 | $72.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Comerica. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Comerica's stock. This analysis reveals shifts in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Comerica's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Comerica analyst ratings.
All You Need to Know About Comerica
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Comerica: Financial Performance Dissected
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Comerica's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.74% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Comerica's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 19.9%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Comerica's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.58%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Comerica's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.21%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Comerica's debt-to-equity ratio is below the industry average at 1.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
What Are Analyst Ratings?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
